853 related articles for article (PubMed ID: 34098867)
1. Induction of ferroptosis by ATF3 elevation alleviates cisplatin resistance in gastric cancer by restraining Nrf2/Keap1/xCT signaling.
Fu D; Wang C; Yu L; Yu R
Cell Mol Biol Lett; 2021 Jun; 26(1):26. PubMed ID: 34098867
[TBL] [Abstract][Full Text] [Related]
2. Induction of ferroptosis by carnosic acid-mediated inactivation of Nrf2/HO-1 potentiates cisplatin responsiveness in OSCC cells.
Han L; Li L; Wu G
Mol Cell Probes; 2022 Aug; 64():101821. PubMed ID: 35490795
[TBL] [Abstract][Full Text] [Related]
3. LncRNA SNHG5 promotes cisplatin resistance in gastric cancer via inhibiting cell apoptosis.
Li M; Zhang YY; Shang J; Xu YD
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4185-4191. PubMed ID: 31173289
[TBL] [Abstract][Full Text] [Related]
4. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.
Shin D; Kim EH; Lee J; Roh JL
Free Radic Biol Med; 2018 Dec; 129():454-462. PubMed ID: 30339884
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of CASC2 contributes to cisplatin resistance in gastric cancer by sponging miR-19a.
Li Y; Lv S; Ning H; Li K; Zhou X; Xv H; Wen H
Biomed Pharmacother; 2018 Dec; 108():1775-1782. PubMed ID: 30372881
[TBL] [Abstract][Full Text] [Related]
6. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
Roh JL; Kim EH; Jang H; Shin D
Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
[TBL] [Abstract][Full Text] [Related]
7. The induction of ferroptosis by impairing STAT3/Nrf2/GPx4 signaling enhances the sensitivity of osteosarcoma cells to cisplatin.
Liu Q; Wang K
Cell Biol Int; 2019 Nov; 43(11):1245-1256. PubMed ID: 30811078
[TBL] [Abstract][Full Text] [Related]
8. DJ-1 is involved in the multidrug resistance of SGC7901 gastric cancer cells through PTEN/PI3K/Akt/Nrf2 pathway.
Qiu L; Ma Z; Li X; Deng Y; Duan G; Zhao LE; Xu X; Xiao L; Liu H; Zhu Z; Chen H
Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(11):1202-1214. PubMed ID: 33079995
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin synergizes with PRLX93936 to induce ferroptosis in non-small cell lung cancer cells.
Liang Z; Zhao W; Li X; Wang L; Meng L; Yu R
Biochem Biophys Res Commun; 2021 Sep; 569():79-85. PubMed ID: 34237431
[TBL] [Abstract][Full Text] [Related]
10. LncRNA DANCR accelerates the development of multidrug resistance of gastric cancer.
Xu YD; Shang J; Li M; Zhang YY
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2794-2802. PubMed ID: 31002130
[TBL] [Abstract][Full Text] [Related]
11. miR-149 reverses cisplatin resistance of gastric cancer SGC7901/DDP cells by targeting FoxM1.
Li X; Liang J; Liu YX; Wang Y; Yang XH; Luan BH; Zhang GL; Du J; Wu XH
Pharmazie; 2016 Nov; 71(11):640-643. PubMed ID: 29441968
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial dysfunction enhances cisplatin resistance in human gastric cancer cells via the ROS-activated GCN2-eIF2α-ATF4-xCT pathway.
Wang SF; Chen MS; Chou YC; Ueng YF; Yin PH; Yeh TS; Lee HC
Oncotarget; 2016 Nov; 7(45):74132-74151. PubMed ID: 27708226
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-206 facilitates gastric cancer cell apoptosis and suppresses cisplatin resistance by targeting MAPK2 signaling pathway.
Chen Z; Gao YJ; Hou RZ; Ding DY; Song DF; Wang DY; Feng Y
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):171-180. PubMed ID: 30657558
[TBL] [Abstract][Full Text] [Related]
14. TXNL1 induces apoptosis in cisplatin resistant human gastric cancer cell lines.
Ni P; Xu W; Zhang Y; Chen Q; Li A; Wang S; Xu S; Zhou J
Curr Cancer Drug Targets; 2015; 14(9):850-9. PubMed ID: 25348020
[TBL] [Abstract][Full Text] [Related]
15. Implications of Withaferin A for the metastatic potential and drug resistance in hepatocellular carcinoma cells via Nrf2-mediated EMT and ferroptosis.
Zhang Y; Tan Y; Liu S; Yin H; Duan J; Fan L; Zhao X; Jiang B
Toxicol Mech Methods; 2023 Jan; 33(1):47-55. PubMed ID: 35592903
[TBL] [Abstract][Full Text] [Related]
16. MiR-187 influences cisplatin-resistance of gastric cancer cells through regulating the TGF-β/Smad signaling pathway.
Zhu QL; Li Z; Lv CM; Wang W
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9907-9914. PubMed ID: 31799659
[TBL] [Abstract][Full Text] [Related]
17. Ferritinophagy-Mediated Ferroptosis and Activation of Keap1/Nrf2/HO-1 Pathway Were Conducive to EMT Inhibition of Gastric Cancer Cells in Action of 2,2'-Di-pyridineketone Hydrazone Dithiocarbamate Butyric Acid Ester.
Guan D; Zhou W; Wei H; Wang T; Zheng K; Yang C; Feng R; Xu R; Fu Y; Li C; Li Y; Li C
Oxid Med Cell Longev; 2022; 2022():3920664. PubMed ID: 35237380
[TBL] [Abstract][Full Text] [Related]
18. miR-1271 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R, IRS1, mTOR, and BCL2.
Yang M; Shan X; Zhou X; Qiu T; Zhu W; Ding Y; Shu Y; Liu P
Anticancer Agents Med Chem; 2014; 14(6):884-91. PubMed ID: 24875127
[TBL] [Abstract][Full Text] [Related]
19. SIRT6 silencing overcomes resistance to sorafenib by promoting ferroptosis in gastric cancer.
Cai S; Fu S; Zhang W; Yuan X; Cheng Y; Fang J
Biochem Biophys Res Commun; 2021 Nov; 577():158-164. PubMed ID: 34530350
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance.
Zhang XW; Bu P; Liu L; Zhang XZ; Li J
Biochem Biophys Res Commun; 2015 Jul; 462(3):227-32. PubMed ID: 25956062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
